SAO PAULO (Reuters) – The National Health Surveillance Agency (Anvisa) on Saturday determined the precautionary ban on batches of Chinese vaccine against Covid-19 CoronaVac, prohibiting the distribution and use of batches in a plant not approved in the emergency use authorization , said the regulator in a statement.
According to the statement, Anvisa was informed the day before by the Butantan Institute that Sinovac, the manufacturer of CoronaVac, sent to Brazil 25 batches in the vial-ampoule presentation (single dose and two doses), totaling 12,113,934 doses.
Read Also
- They reveal images of the huge trunk that affected the Railway Bridge: repair will take 60 days Dec 16, 2022
- ” Wait a minute ! “20 Minutes” website imitated to relay Russian propaganda Nov 22, 2022
- Automotora Berríos inaugurates a new technical service in Puerto Varas Nov 26, 2022
- Joe Biden signs executive order to regulate tech monopolies Jul 10, 2021
- New call for the Second Digital Dividend | News | Infrastructures May 30, 2021
- Unable to change her name on Twitter, Doja Cat tackles Elon Musk in style Nov 19, 2022
- UK struggles with bollard shortage | FormulaPassion.it Jul 27, 2021